Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis
- 19 April 2001
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 37 (6) , 1713-1718
- https://doi.org/10.1016/s0735-1097(01)01204-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Therapeutic actions of cyclosporine and anti-tumor necrosis factor ? in collagen-induced arthritis and the effect of combination therapyArthritis & Rheumatism, 1998
- The use of cytokine inhibitors: A new therapeutic insight into heart failureInternational Journal of Cardiology, 1997
- Protective Role of Interleukin-12 in Viral MyocarditisJournal of Molecular and Cellular Cardiology, 1997
- Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophagesLife Sciences, 1996
- QUANTITATING IMMUNOSUPPRESSIONTransplantation, 1996
- Simple compounds, 2-alkyl-2-amino-1,3-propanediols have potent immunosuppressive activityBioorganic & Medicinal Chemistry Letters, 1995
- FK506 therapy of experimental autoimmune myocarditis after onset of the diseaseAmerican Heart Journal, 1993
- An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in ratsClinical Immunology and Immunopathology, 1992
- Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virus.Japanese Circulation Journal, 1987
- An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice.Circulation, 1982